ECSP972005A - ANTICOAGULANT AGENTS USEFUL IN THE TREATMENT OF THROMBOSIS - Google Patents

ANTICOAGULANT AGENTS USEFUL IN THE TREATMENT OF THROMBOSIS

Info

Publication number
ECSP972005A
ECSP972005A ECSP972005A ECSP972005A EC SP972005 A ECSP972005 A EC SP972005A EC SP972005 A ECSP972005 A EC SP972005A EC SP972005 A ECSP972005 A EC SP972005A
Authority
EC
Ecuador
Prior art keywords
thrombosis
treatment
agents useful
anticoagulant agents
anticoagulant
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Michael Neal Blackburn
William Robert Church
Giora Zeev Feuerstein
Mitchell Stuart Gross
Andrew John Nichols
Eduardo Agustin Padlan
Arunbhai Haribhal Patel
Daniel Robert Sylvester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP972005 priority Critical patent/ECSP972005A/en
Publication of ECSP972005A publication Critical patent/ECSP972005A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Se describen anticuerpos monoclonales dirigidos contra factores de coagulación y su uso para inhibir la trombosis.Monoclonal antibodies directed against clotting factors and their use to inhibit thrombosis are described.

ECSP972005 1997-01-17 1997-01-17 ANTICOAGULANT AGENTS USEFUL IN THE TREATMENT OF THROMBOSIS ECSP972005A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP972005 ECSP972005A (en) 1997-01-17 1997-01-17 ANTICOAGULANT AGENTS USEFUL IN THE TREATMENT OF THROMBOSIS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP972005 ECSP972005A (en) 1997-01-17 1997-01-17 ANTICOAGULANT AGENTS USEFUL IN THE TREATMENT OF THROMBOSIS

Publications (1)

Publication Number Publication Date
ECSP972005A true ECSP972005A (en) 1998-04-24

Family

ID=42042839

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP972005 ECSP972005A (en) 1997-01-17 1997-01-17 ANTICOAGULANT AGENTS USEFUL IN THE TREATMENT OF THROMBOSIS

Country Status (1)

Country Link
EC (1) ECSP972005A (en)

Similar Documents

Publication Publication Date Title
BR9707049A (en) Anticoagulant agents usable in the treatment of thrombosis
MX9301751A (en) PEROXYCARBOXYLIC AMIDO ACIDS.
TR200100922T2 (en) Application of active substances through the lungs.
BR0114646A (en) humanized anti-lt-beta-r antibodies
DK199901518A (en) In the form of small molecules are inhibitors of rotamase enzyme activity
DE60010098D1 (en) 28-EPIRAPALOGE
EA200001245A1 (en) COMPOSITIONS ON THE BASIS OF PYRROLO [2,3d] PYRIMIDINES AND THEIR USE
DE60005953D1 (en) STACKABLE STATIC MIXING ELEMENTS
EA200000251A1 (en) DERIVATIVES OF RESORTSINOL
NL300195I2 (en) Synergistic combinations of zidovudine, 1592U89 and 3TC or FTC.
ES2162937T3 (en) COMBINED PREPARATION FOR APPLICATION IN IMMUNOLOGICAL DISEASES.
CY1108610T1 (en) IL-2 Peptides and their derivatives and their use as therapeutic agents
DK1039912T3 (en) Angiostatic agents and preparations for the treatment of GLC1A glaucoma
DE69630955D1 (en) IMMORTALIZATION OR DISIMMORTALIZATION OF CELLS
IS5504A (en) Composition active in the treatment of impotence
DE69835215D1 (en) INHIBITORS OF PHOSPHOSERIN AND PHOSPHOTHREONINPECIFIC ISOMERASES
ES2172536T3 (en) LIBERATION AND MOBILIZATION OF HEMATOPOYETIC CELLS.
SE9604731D0 (en) A component of intercellular junctions in the endothelium
BR9612115A (en) Endothelial cell proliferation inhibitor and process of use
TR199802704T2 (en) Use of combinations containing Vx478, Zidovidin, FTC and/or 3TC in the treatment of HIV.
ES2088128T3 (en) ACAT INHIBITOR AMINOSULFONILUREAS.
BR0110577A (en) Transgenically produced decorina
DE69817779D1 (en) INTRODUCTION OF SMOKE-MODIFYING AGENTS IN SMOKE ARTICLES
BR0110902A (en) Mmp-9 / mmp-2 inhibitors
TR199801988T2 (en) Method for the treatment of heart failure with endothelin antagonists.